Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia.
Blood Cancer J
; 1(6): e22, 2011 Jun.
Article
em En
| MEDLINE
| ID: mdl-22829166
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Blood Cancer J
Ano de publicação:
2011
Tipo de documento:
Article